Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 8 of 8 for “"HA14-1"”.
-
THE SMALL MOLECULE BCL-2 INHIBITOR HA14-1 POTENTIATES THE LETHALITY OF A REGIMEN COMBINING MEK1/2 AND CHK1 INHIBITORS IN MULTIPLE MYELOMA CELLS
… of Bcl-2 of Bcl-xL in multiple myeloma cells. HA14-1, a small molecule Bcl-2 inhibitor, may therefore circumvent this resistance to apoptosis by blocking Bcl-2 and Bcl-xL anti-apoptotic protein actions. In our project, we hypothesize that the co-administration of HA14-1 with MEK/Chk1 inhibitors …
-
Neuroprotective Effects of Anthocyanins on Neuronal Death Induced by Inhibition of Bcl-2 and Oxidative Stress
… were induced in CGNs by the Bcl-2 inhibitor, HA14-1. Callistephin and kuromanin each demonstrated significant neuroprotection from this MOS-induced death that was equal to that provided by the green tea polyphenol, epigallocatechin 3-gallate; however, neither anthocyanin was as effective as …
-
The Role Of The Cell-Surface Protease Tmprss13 In Colorectal Cancer
… to the apoptosis-inducing agents paclitaxel and HA14-1 Reversely, TMPRSS13 loss-of-function caused increased sensitivity of CRC cells to drug-induced apoptosis. Use of a TMPRSS13-deficient mouse line in the azoxymethane/dextran sulfate sodium (DSS) model of CRC revealed increased sensitivity to …
-
Combination Therapy For the Treatment of Human Malignant Neuroblastoma
… inhibitor of the anti-apoptotic protein Bcl-2 HA14-1 (HA) and the isoflavonoid genistein (GST) in human malignant neuroblastoma cells. Results showed that combination therapy synergistically induced apoptosis by activating caspase cascade and down regulating survival and oncogenic factors in …
-
Nutraceutical Antioxidants and Their Therapeutic Potential in Neurodegeneration
… completely protected against MOS induced by HA14-1, an inhibitor of the pro-survival Bcl-2 protein. This effect was prevented by co-incubation with the gamma-glutamyl cysteine ligase inhibitor, buthionine sulfoximine, demonstrating that the de novo synthesis of GSH underlies the …
-
Der periphere Benzodiazepinrezeptor bei gastrointestinalen Tumoren
… Docetaxel, Doxorubicin und des Bcl-2 Inhibitors HA14-1. Die Wirksamkeit der PBR Liganden lag bei allen untersuchten Tumorentitäten (Kolorektum, Ösophagus, Leber) im ähnlichen Konzentrationsbereich. Ihre antiproliferativen Effekte beruhten sowohl auf einer Induktion von Apoptose als auch auf einer …
-
Innovative Ansätze in der Diagnostik und Therapie gastrointestinaler Tumore
… Docetaxel, Doxorubicin und des Bcl-2 Inhibitors HA14-1. Die Wirksamkeit der PBR Liganden lag bei allen untersuchten Tumorentitäten (Kolorektum, Ösophagus, Leber) im ähnlichen Konzentrationsbereich. Ihre antiproliferativen Effekte beruhten sowohl auf einer Induktion der mitochondrienvermittelten …